APRICUS BIOSCIENCES

apricus-biosciences-logo

Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED. Vitaros® is approved in Europe and Canada and will be commercialized by Apricus’ marketing partners, which include Abbott Laboratories Limited, Takeda Pharmaceuticals International GmbH, Hexal AG (Sandoz), and Bracco SpA. Femprox®, the Company’s product candidate for the treatment of FSAID, has successfully completed a nearly 400-subject proof-of-concept study.

#SimilarOrganizations #People #Financial #Website #More

APRICUS BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1987-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.apricusbio.com

Total Employee:
51+

Status:
Active

Contact:
858-222-8041

Total Funding:
12.3 M USD

Technology used in webpage:
IPv6 ASP.NET IIS DigiCert SSL IIS 8 New Relic Akamai Hosted IIS 7 ASP.NET 2.0 Softlayer


Similar Organizations

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.


Current Advisors List

wendell-wierenga_image

Wendell Wierenga Member of Board of Directors @ Apricus Biosciences
Board_member

Current Employees Featured

richard-pascoe_image

Richard Pascoe
Richard Pascoe CEO @ Apricus Biosciences
CEO

steve-martin_image

Steve Martin
Steve Martin SVP & CPO @ Apricus Biosciences
SVP & CPO

Stock Details


Company's stock symbol is NASDAQ:APRI

Acquisitions List

Date Company Article Price
2009-12-14 Bio-Quant Bio-Quant acquired by Apricus Biosciences N/A

Official Site Inspections

http://www.apricusbio.com Semrush global rank: 8.49 M Semrush visits lastest month: 523

  • Host name: 104.21.64.157
  • IP address: 104.21.64.157
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Apricus Biosciences"

Apricus Biosciences - Crunchbase Company Profile & Funding

Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED. Vitaros® is approved in Europe and Canada and will be …See details»

Apricus Biosciences - Wikipedia

Apricus Biosciences, Inc. is a San Diego–based biopharmaceutical company advancing innovative medicines in urology and rheumatology. Apricus Biosciences' first product, Vitaros®, has been approved in Europe and Canada for the treatment of erectile dysfunction Other compounds in development include: low testosterone, rheumatology, sexual dysfunction, pain, See details»

Apricus Biosciences - SlideShare

Organization / Workplace. San Diego, CA United States Industry. Medical / Health Care / Pharmaceuticals ... About. ApricusBio (Nasdaq: APRI) is dedicated to developing patient …See details»

Apricus Biosciences Company Profile | Management and

[email protected]: 6: last: [email protected]: Your Questions, Our Answers Get Free Access to Apricus Biosciences Contacts Info. What is Apricus Biosciences revenue? Apricus …See details»

Apricus Biosciences, Inc - VentureRadar

"Apricus Biosciences, Inc. (APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. Apricus has initiated a Phase 2b trial for fispemifene, …See details»

Apricus Biosciences - Craft

Jan 23, 2019 See insights on Apricus Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Apricus BioSciences – San Diego Biotechnology Network

Nov 13, 2024 Organization Type. Public Company. Size Range. 11-50. Geographical Area. Greater San Diego Area. Follow @ApricusBio. Advertisement. ADVERTISEMENT — …See details»

Apricus Biosciences | Scientist.com

Apricusbio.com: Headquarters: San Diego, CA, US Company Type: Small Business (1-10M TTM Revenue) Description Sites ... If your organization has a Scientist.com marketplace, you can …See details»

Contacts, Employees, Board Members, Advisors & Alumni

Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED.See details»

Apricus Biosciences - Funding, Financials, Valuation & Investors

Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»

Apricus Biosciences, Inc. | Globenewswire

Nov 22, 2024 "In the first quarter of this year, we continued to execute on our strategy by creating a more focused and capital efficient organization with the potential to deliver on …See details»

Apricus Biosciences Announces Closing of Finesco-Scomedica

Jul 13, 2012 Under the terms of the agreement, Finesco's existing shareholders contributed to Apricus Bio 100% of the outstanding common stock of Finesco in exchange for 2,592,592 …See details»

Apricus Biosciences Biosciences To Present At The 13th Annual ...

Oct 1, 2014 Best Places to Work; Employer Resources; Post Jobs; Talent Solutions; Advertise; Submit a Press ReleaseSee details»

Apricus Biosciences Sells Bio-Quant CRO Subsidiary to

Jun 7, 2011 Apricus Biosciences, Inc. Edward Cox, V.P. Corporate Development & Investor Relations, Apricus Biosciences, Inc. (858) 848-4249 [email protected] Apricus Bio …See details»

Apricus Biosciences, Inc. | Globenewswire - Ritzau

May 9, 2016 Please join the webcast atwww.apricusbio.comto view the presentation slides or, to participate by telephone, dial (877) 841-3961 (Domestic) or (201) 689-8589 (International). …See details»

Apricus Biosciences Security Rating, Vendor Risk Report, and

How secure is your organization? Request a free cybersecurity report to discover key risks on your website, email, network, and brand. Instant insights you can act on immediately. …See details»

Apricus Biosciences, Inc. : Apricus Biosciences Further Expands ...

Jul 25, 2016 Apricus Eligible to Receive an Additional $3.6 Million in Upfront and Pre-Commercialization Milestone Payments for the Expanded Territory Apricus and Sandoz Agree …See details»

Apricus Biosciences (APRI) Stock Price, News & Analysis

5 days ago www.apricusbio.com. Phone (646) 293-2100. Fax N/A. Employees N/A. Year Founded N/A. Profitability. EPS (Most Recent Fiscal Year) ($0.99) Trailing P/E Ratio N/A. …See details»

AbacusBio: Contact us

To prepare your organization for the future, you need a reliable partner who understands what you’re dealing with — and what you could be doing better. A partner with expertise in genetics, …See details»

AbacusBio | International leader in genetic improvement

ICBF and the Irish cattle breeding industry have benefited greatly from the excellent work provided by AbacusBio over the last 20 years. Their expert technical skills and industry …See details»

linkstock.net © 2022. All rights reserved